Crude and age-specific incidence rate patterns for histopathologic subtypes of ovarian cancer in Iran

Archives of Iranian Medicine

Volumn 13, Issue 3, 2010, Pages 203-208

  Arab, Maliheh ^a,b   Khayamzadeh, Maryam ^a,b   Hashemi, Mohammad ^b   Hosseini, Maryam ^b   Tabatabaeefar, Morteza ^b   Anbiaee, Robab ^a,b   Anvari, Nahid ^c   Ebrahimi, Mojgan ^c   Akbari, Mohammad E ^a,b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Age at diagnosis; Histology; Incidence; Iran; Ovarian cancer

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CLASSIFICATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; ENDOMETRIUM CANCER; EPITHELIUM TUMOR; FEMALE; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; OVARY CANCER; SEX CORD TUMOR; TUMOR LOCALIZATION;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; BIOPSY, NEEDLE; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; IRAN; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; PROGNOSIS; REGISTRIES; SURVIVAL ANALYSIS;

EID: 77953074170     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Akbari ME, Abachizadeh K, Khayamzadeh M, Ta-batabaee M, Esnaashari F, Motlagh AG, et al. Iran Cancer Report. Tehran, Iran: CRC. SBMU; 2008.
2. Russell P. Farnsworth A. Surgical Pathology of the Ovaries. 2nd ed. New York, NY: Churchill Livingstone; 1997.
3. Berek JS, Natarajan S. Ovarian and fallopian tube cancer. In: Berek JS, ed. Berek and Novaks Gyne-cology. 14th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.
4. van Nagell JR Jr, Gershenson DM. Ovarian cancer: etiology, screening, and surgery. In: Rock JA, Jones HW, eds. Telindes Operative Gynecology. 10th eds Philadelphia, PA: Wolters Kluwer; 2008.
5. Loka A, Tsukuma H, Ajiki W, Oshima A. Ovarian cancer incidence and survival by histologic type in Osaka, Japan. Cancer Sci. 2003; 94: 292-296.
6. Scully RE, Young RH, Clement PB. Atlas of tumor pathology. Third series. Fascicle 23: Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and broad ligament. Washington, DC. Armed Forces Institute of Pathology; 1998.
7. Arab M, Khayamzadeh M, Mohit M, Hosseini M, Anbiaee R, Tabatabaeefar M, et al. Survival of ovarian cancer in Iran 2000 - 2004. Asian Pac J Cancer Prev. 2009; 10: 555-558.
8. Hoskins WJ, Perez CA, Young RC, Barakat RR, Markman M, Randall ME. Principles and Practice of Gynecologic Oncology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
9. Robboy SJ, Anderson MC, Russell P. Pathology of the Female Reproductive Tract. London: Churchill Livingstone; 2002.
10. Bidus MA, Zahn CM, Rose GS. Germ cell, stromal, and other ovarian tumors. In: Disaia PJ, Creasman WT, eds. Clinical Gynecologic Oncology. 7th ed. Philadelphia, PA: Mosby Elsevier; 2007.
11. Berek JS, Hacker NF. Nonepithelial ovarian and fallopian tube cancers. In: Berek JS, Hacker NF. Practical Gynecologic Oncology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
12. Quirk JT, Natarajan N. Age-specific ovarian cancer incidence rate patterns in the United States [letter]. Gyn Oncol. 2005; 99: 248-250.
13. Guirck JT, Natarajan N. Ovarian cancer incidence in the United States, 1992 - 1999. Gyn Oncol. 2005; 97: 519-523.
14. Islamic Republic of Iran, Ministry of Health and Medical Education, Health Deputy, Center for Disease Control & Prevention, Noncommunicable Deputy, Cancer Office. Iranian Annual of National Cancer Registration Report; 2005-2006.
15. Scully RE. Histological Classification of Ovarian Tumors. 2nd ed. Berlin: Springer-Verlog; 1999.
16. Berg JW. Morphologic classification of human cancer. In: Schottenfeld D, Fraumcri JJ, eds. Cancer Epidemiology and Prevention. 2nd ed. New York, NY: Oxford; 1996.
17. Sen U, Sankaranarayanan R, Mandal S, Ramanaku-mar A, Parkin DM, Sliddiqi M. Cancer patterns in eastern India: the irst report of the Kolkata cancer registry. Int J Cancer. 2002; 100: 86-91.
18. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M. Cancer incidence in Tehran metropolis: The irst report from the Tehran population-based cancer registry, 1998-2001. Arch Iran Med. 2009; 12: 15-23.
19. Skirnisdottir I, Garmo H, Wilander E, Holmberg L. Borderline ovarian tumors in Sweden 1960 - 2005: Trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer. 2008; 123: 1897-1901.
20. Hanai A. Trends and differentials in ovarian cancer: incidence, mortality and survival experience. AP-MIS Suppl. 1990; 12: 1-20.
21. Basile S, Angioli R, Manci N. Gynecological cancers in developing countries: The challenge of chemotherapy in low-resources setting. Int J Gynecol Cancer. 2006; 16: 1491-1497.
22. Liu MC, Hai A, Huang AT. Cancer epidemiology in the Far East - contrast with the United States. Oncology. 1993; 7: 99-110.
23. Beral V, Doll R, Hermon C, Peto R, Reeves G, Brimton L. et al. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23257 women with ovarian cancer and 87303 controls. Lancet. 2008; 371: 303-314.